Marketable Securities, Current in USD of Lantern Pharma Inc. from Q2 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Lantern Pharma Inc. quarterly Marketable Securities, Current history and growth rate from Q2 2021 to Q3 2025.
  • Lantern Pharma Inc. Marketable Securities, Current for the quarter ending September 30, 2025 was $3.97M, a 80.1% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)

Lantern Pharma Inc. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $3.97M -$16M -80.1% Sep 30, 2025 10-Q 2025-11-12
Q2 2025 $9.84M -$10.4M -51.5% Jun 30, 2025 10-Q 2025-08-13
Q1 2025 $13.3M -$6.66M -33.3% Mar 31, 2025 10-Q 2025-05-15
Q4 2024 $16.5M -$2.86M -14.8% Dec 31, 2024 10-Q 2025-11-12
Q3 2024 $20M +$597K +3.09% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $20.3M +$760K +3.89% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $20M +$939K +4.92% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $19.4M +$1.37M +7.62% Dec 31, 2023 10-K 2025-03-27
Q3 2023 $19.4M +$785K +4.23% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $19.5M +$739K +3.94% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $19.1M +$496K +2.67% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $18M -$1.21M -6.29% Dec 31, 2022 10-K 2024-03-18
Q3 2022 $18.6M -$595K -3.1% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $18.8M +$552K +3.03% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $18.6M Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $19.2M Dec 31, 2021 10-K 2023-03-20
Q3 2021 $19.2M Sep 30, 2021 10-Q 2021-11-01
Q2 2021 $18.2M Jun 30, 2021 10-Q 2021-07-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.